Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value Per Share
-
Shares outstanding
-
107,800,271
-
Total 13F shares
-
27,866,362
-
Share change
-
+9,792,005
-
Total reported value
-
$1,115,757,230
-
Put/Call ratio
-
103%
-
Price per share
-
$40.04
-
Number of holders
-
128
-
Value change
-
+$395,309,998
-
Number of buys
-
89
-
Number of sells
-
39
Institutional Holders of Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) as of Q3 2015
As of 30 Sep 2015 Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) had 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,866,362 shares of stock of the company.
Largest 10 holders included FMR LLC, Redmile Group, LLC, STATE STREET CORP, BlackRock Advisors LLC, ADAGE CAPITAL PARTNERS GP LLC, TimesSquare Capital Management, LLC, WASATCH ADVISORS INC, Visium Asset Management, LP, VANGUARD GROUP INC, and BlackRock Fund Advisors.
This table shows 128 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.